Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flow used in Operating Activities:
Net Loss	$ (543,723)	$ (284,289)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	738	2,505
Non-cash charges relating to issuance of common stock, common stock options and warrants	2,236	4,081
Derivative Value and Debt Discount charges (credits)	252,765	(229,688)
Other non cash charges including amortization of deferred compensation and beneficial conversion interest expense	30,393	30,393
Changes in assets and liabilities:
Accounts receivable	4,077	(66,372)
Inventories	53,469	112,574
Prepaid expenses and Other current assets	16,059	(4,955)
Other assets	3,060	(8,040)
Accounts payable & Accrued expenses	28,568	$ 77,579
Customer deposits	(26,691)
Due to/from related parties Microphase & Eagle	16,250	$ 6,092
Officers	94,444
Net cash used in operating activities	$ (68,356)	$ (360,120)
Cash Flow used in Investing Activities:
Purchase of fixed assets		(6,007)
Net Cash used in investing activities	$ 0	(6,007)
Cash Flow from Financing Activities:
Proceeds from issuance of common stock, net of finders fees	126,000	$ 210,000
Proceeds of demand note	$ 10,000
Issuance of Convertible Debentures		$ 40,000
Repayment of Convertible Debentures	$ (42,635)	$ (40,000)
Net Proceeds (Repayment) from notes payable related parties	(21,323)
Net cash provided by financing activities	72,042	$ 210,000
Net increase (decrease) in cash	3,687	(156,127)
CASH AND CASH EQUIVALENTS, beginning of period	2,868	179,257
CASH AND CASH EQUIVALENTS, end of period	$ 6,555	$ 23,130